n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Atkins, HL; Brill, AB; Kubota, K; Meinken, GE; Sacker, DF; Som, P; Srivastava, SC | 1 |
1 other study(ies) available for n,n,n'-trimethyl-n'-(2-hydroxy-3-methyl-5-iodobenzyl)-1,3-propanediamine and Disease Models, Animal
Article | Year |
---|---|
Comparative dual-tracer studies of carbon-14 tryptophan and iodine-131 HIPDM in animal models of pancreatic diseases.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Diabetes Mellitus, Experimental; Disease Models, Animal; Female; Iodine Radioisotopes; Iodobenzenes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Pancreatic Diseases; Protein Biosynthesis; Radionuclide Imaging; Tissue Distribution; Tryptophan; Whole-Body Counting | 1989 |